ms posts
FeedPosted Oct 24th 2009 2:20PM by Trey Thoelcke (RSS feed)
Filed under: Earnings reports, Apple Inc (AAPL), Amazon.com (AMZN), McDonald's (MCD), 3M Corporation (MMM), Caterpillar (CAT), New York Times'A' (NYT), Bank of New York (BK), Hershey Co (HSY), Gannett Co (GCI), Morgan Stanley (MS), Kimberly-Clark (KMB), United Parcel'B' (UPS), Lockheed Martin (LMT), Broadcom Corp'A' (BRCM), SLM Corp (SLM)
Continue reading Earnings highlights: Amazon, Apple, Caterpillar, Hershey, McDonald's, UPS ...
Posted Oct 11th 2009 12:30PM by Trey Thoelcke (RSS feed)
Filed under: Earnings reports, Forecasts, Google (GOOG), International Business Machines (IBM), JPMorgan Chase (JPM), Abbott Laboratories (ABT), Bank of America (BAC), Goldman Sachs Group (GS)
Goldman Sachs upgraded the banking sector last week, and this coming week we'll get a chance to see whether Goldman and other big banks reporting third quarter results will live up to the expectations of analysts surveyed by Thomson Reuters.
New York-based Goldman Sachs Group Inc. (NYSE: GS) looks set to be this week's earnings game winner. Analysts expect this dividend-paying company to report a third-quarter profit of $4.24 per share, which is 57.3% higher than in the same period of last year. Revenue for the period that ended in September is expected to be $11.0 billion. So far, the full-year forecast is for $17.74 per share on $44.6 billion.
Continue reading Week in preview: Goldman Sachs, JPMorgan, Google, IBM and more earnings
Posted Sep 30th 2009 3:30PM by Tom Taulli (RSS feed)
Filed under: Citigroup Inc. (C), JPMorgan Chase (JPM), Goldman Sachs Group (GS), Morgan Stanley (MS), Initial public offerings

Last week, we saw
Shanda Games Ltd. (NASDAQ:
GAME) raise a cool $1 billion in
its IPO.
And today, there was another big-time offering: Talecris Biotherapeutics Holdings
picked up $950 in its IPO (issuing 50 million shares at $19 each). This is the second largest IPO of 2009.
Talecris is one of the largest producers/marketers of plasma-derived protein therapies, dealing with things like chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, and severe trauma.
Continue reading Talecris: Another mega IPO hits the markets
Posted Sep 11th 2009 11:30AM by Tom Taulli (RSS feed)
Filed under: Citigroup Inc. (C), Goldman Sachs Group (GS), Morgan Stanley (MS)
When the financial world was coming apart last year, it seemed that Morgan Stanley's (NYSE: MS) CEO, John Mack, was making prudent strategic decisions. That is, he tried to lower the overall risk-taking at the firm. Mack had to contend with a deteriorating balance sheet, angry shareholders, a steep drop in business and intrusive regulators.
This was in stark contrast to Mack's prior strategy. If anything, he was a risk junkie. And yes, he made some huge bets on real estate investments that turned sour. In fact, they almost destroyed Morgan Stanley. But somehow Mack was able to wrangle a $9 billion investment from Mitsubishi UFJ Financial Group. There was also a TARP loan for $10 billion (which was actually paid back).
Continue reading Morgan Stanley's Mack is out the door
Posted Sep 9th 2009 11:20AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Morgan Stanley (MS), duPont(E.I.)deNemours (DD), Analyst initiations
Analyst upgrades:
- Citigroup upgraded Capital One (NYSE: COF) to Buy from Hold as it believes the credit cycle is starting to recover for U.S. credit cards and an improving economy will support bank credit stabilization. The firm raised its target on shares to $44 from $28.
- JPMorgan upgraded Morgan Stanley (NYSE: MS) to Overweight from Neutral on valuation and believes the stock market recovery will serve as a catalyst.
- Deutsche Bank upgraded F5 Networks (NASDAQ: FFIV) to Buy from Hold after its channel checks indicated a sooner-than-expected order ramp and stabilizing pricing trends. The firm raised its target on shares to $46 from $39.
- COTT Corp. (NYSE: COT) was upgraded to Buy from Neutral at UBS.
- Blackstone Group (NYSE: BX) was upgraded to Equal Weight from Underweight at Barclays.
- Illinois Tool Works (NYSE: ITW) was upgraded to Conviction Buy from Neutral at Goldman.
Continue reading Analyst upgrades, downgrades and initiations: BX, COF, DD, MS, VMC, WM, ZION ...
Posted Sep 1st 2009 3:00PM by Connie Madon (RSS feed)
Filed under: Products and services, Launches, Industry
What is the next hottest government program now that "cash for clunkers" is over? Yup, you guessed it. It's wind farms.
According to the Wall Street Journal (subscription required), the government is starting a new program to subsidize the production of wind farms all over the country. Under the program, the government will rebate 30% of the cost of building a renewable energy facility, awarded 60 days after the application is approved. The Energy and Treasury Departments expect to spend $3 billion initially. Some people believe, however, that applications could grow to $10 billion. This new program started July 31.
Continue reading Now that 'cash for clunkers' is over, it's on to wind farms
Posted Aug 31st 2009 12:00PM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Boeing Co (BA), Morgan Stanley (MS), Analyst initiations, JetBlue Airways (JBLU)
Analyst upgrades:
- FBR Capital upgraded Frontline (NYSE: FRO) to Market Perform from Underperform to reflect the company's above-average day rates and alleviated near-term financing pressures. The firm raised its target on shares to $23 from $14.
- Baird upgraded Varian Medical (NASDAQ: VARI) to Outperform from Neutral and said checks at ESTRO meeting indicate European radiation therapy market demand will remain "respectable" in 2010 and that launch of Unique could drive incremental demand in developing markets. The firm has a $49 target on shares.
- Goldman believes GameStop (NYSE: GME) Street expectations are beatable and valuation is attractive. The firm upgraded shares to Conviction Buy from Neutral and has a $28 target.
- Borg-Warner (NYSE: BWA) was upgraded to Outperform from Market Perform at Wells Fargo.
- KKR Financial (NYSE: KFN) was upgraded to Outperform from Market Perform at JMP Securities.
- Cathay Pacific (OTC: CPCAY) was upgraded to Outperform from Neutral at Credit Suisse.
Continue reading Analyst upgrades, downgrades and initiations: BA, FRO, GENZ, JBLU, MS, VARI ...
Posted Aug 12th 2009 3:00PM by Tom Taulli (RSS feed)
Filed under: Deals, Goldman Sachs Group (GS), Morgan Stanley (MS)
Going into its IPO, investors were expecting nice gains from Emdeon. Well, the company did not disappoint. Last night, the company priced 23.7 million shares at $15.50 (this was an 11% increase in the number of shares). It was at the top of its $13.50-$15.50 range.
Emdeon runs a sophisticated platform that connects payers, providers and patients in the US healthcare system (built over the past 25 years). Yes, in light of the proposed reforms from the Obama Administration, this is certainly an attractive space. After all, a big goal is to find ways to cut costs -- and technology should be a key.
Continue reading Emdeon: An Obama IPO?
Posted Jul 29th 2009 11:00AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Campbell Soup (CPB), Coach Inc (COH), Morgan Stanley (MS), Dow Chemical (DOW), Analyst initiations
Analyst upgrades:
- Baird upgraded WinTrust (NASDAQ: WTFC) to Neutral from Underperform and raised its target to $20 from $13 citing the accretive purchase of AIG (NYSE: AIG) loans and reduced risk of a capital raise.
- Piper Jaffray upgraded Coach (NYSE: COH) to Overweight from Neutral on expectations product sell-throughs and margin trends will improve in the coming quarters. The firm has a $32 target on the stock.
- RBC Capital upgraded Campbell Soup (NYSE: CPB) to Sector Perform from Underperform and raised its target to $33 from $29. The firm cites Campbell's recent innovation, easy volume comps, and "reasonable" consensus estimates for its upgrade.
- Tata Motors (NYSE: TTM) was upgraded to Equal Weight from Underweight at Morgan Stanley.
- Rockwell Automation (NYSE: ROK) was upgraded to Buy from Neutral at BofA/Merrill.
- Fifth Third Bancorp (NASDAQ: FITB) was upgraded to Conviction Buy from Buy at Goldman.
Continue reading Analyst upgrades, downgrades and initiations: AFL, COH, CPB, DOW, MS, TTM ...
Next Page >